Pediatr. praxi. 2015;16(4):221-223

Vitamin D in childhood and adolescence - five spheres of influence

MUDr.Božena Kalvachová, CSc.
Endokrinologický ústav, Praha

The biologically active metabolite of vitamin D, the steroid hormone calcitriol, has several roles in the organism. Its antirachitic effect

is well known almost one hundred years while its mechanism has been elucidated later. We consider this systemic regulatory influence

of calcitriol on the calcium-phosphate metabolism as its priority function. Its local creation and regional tissue effectivity of calcitriol

after its binding to cellular nuclear receptors – the endocrine microsystems – build up further spheres of influence: immunomodulation,

metabolic reactions, development and functionality of the brain and fetal programming. Proper care for sufficient substrate for these

microsystems in the developing and growing organism means possible prevention and therapy for many disturbances and illnesses.

Optimally by a natural way or with minimal treatment expenses.

Keywords: calcitriol, myoskeleton, immunomodulation, metabolism, brain, fetal programming, supplementation

Published: September 20, 2015  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kalvachová B. Vitamin D in childhood and adolescence - five spheres of influence. Pediatr. praxi. 2015;16(4):221-223.
Download citation

References

  1. Spustová V, Dzúrik R. Vitamín D: syntéza, metabolizmus, regulácie a hodnotenie deficitu u pacientov s chronickým ochoreniem obličiek. Vnitřní lékařství, 2004; 50(7): 537-543. Go to PubMed...
  2. Blahoš J. Význam vitaminu D. Lékařské listy 2006; 20: 25-26.
  3. Paszková H. Nedoceněný vitamin D - náš nezbytný celoživotní průvodce. CCB s. r. o, Brno, 2010: 25-37.
  4. Štercl I. D vitamin a imunita. Vnitř Lék 2012; 58(5): 405-410. Go to PubMed...
  5. Chiu, K, Chu A, Go V, et al. Hypovitaminosis D is associated with insulin resistance and beta cell dysfunction. Am. J. Clin. Nutr., 2004; 79: 820-825. Go to original source... Go to PubMed...
  6. Hyppönen E. Vitamin D and increasing incidence of type 1 diabetes-evidence for an association, Diabetes Obes Metab 2010; 12: 737-743. Go to original source... Go to PubMed...
  7. Li YCh, Qiao G, Uskokovic M, et al. Vitamin D: a negative endocrine regulator of the renin-angiotensin system and blood pressure. J Cell Biochem. 2004; 89-90: 387-392. Go to original source... Go to PubMed...
  8. Mayer O. Vitamin D a riziko kardiovaskulárních chorob. Vnitř Lék 2012; 58(5): 386-389. Go to PubMed...
  9. Earthmann CP, Beckman LM, Masodkar K, Sibley SD. The link between obesity and low circulating 25 - hydroxyvitamin D concentrations: considerations and implications. International Journal of Obesity 2012; 36: 387-396. Go to original source... Go to PubMed...
  10. Vieth R. Vitamin D Nutrition and its Potential Health Benefits for Bone, Cancer and Other Conditions. JNEM, 2001; 11: 275-291. Go to original source...
  11. McGrath J. Does "imprinting" with low prenatal vitamin D contribute to the risk of various adult disorders? Medical Hypotheses 2001; 56: 367-371. Go to original source... Go to PubMed...
  12. Baker AM, Haeri S, Camargo CA, et al. A nested case-control study of midgestation vitamin D deficiency and risk of severe preeclampsia. Clin Endocrinol Metab. 2010; 95(11): 5 105-109. Go to original source... Go to PubMed...
  13. Holick MF. Vitamin D deficiency. N Engl J Med., 2007; 357(3): 266-281. Go to original source... Go to PubMed...
  14. Zittermann A. The estimated benefits of vitamin D for Germany. Mol. Nutr. Food Res., 2010; 54(8): 1164-1171. Go to original source... Go to PubMed...
  15. Holick MF, Binkley, Bischoff-Ferrari HA, et al. Evaluation, Treatment and Prevention of Vitamin D Deficiency. JCEM, 2011; 96(7): 1911-1930. Go to original source... Go to PubMed...




Pediatrics for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.